Home Tags Biotech

Tag: Biotech

A new experimental gene therapy has cured babies born with a genetic disease dubbed "bubble boy" syndrome.

There’s now a cure for the deadly genetic disorder known as ‘bubble-boy’ disease

Doctors used a cutting-edge medical technique called gene therapy to treat 10 babies born with the disease. The biotech that helped saw its stock surge.

The IPO market has come storming back. Nasdaq’s head of healthcare listings gave us the lay of the land.

Nasdaq's head of healthcare listings, Jordan Saxe, weighed in on the state of healthcare IPOs at a hectic time for debuting on public markets.
A Type 1 diabetes patient holds up bottles of insulin.

Outrage over the cost of the life-saving drug insulin has drugmakers scrambling, but Congress and the public demand a price cut

Critics call the new programs "PR stunts,"and say drug companies should just lower their prices.
Pharmacy-benefit managers (PBMs), which are today increasingly owned by health insurers and pharmacy chains, will be facing tough questions about drug prices at a congressional hearing on April 9.

These powerful but little-known companies that have been blamed for high drug prices are now coming out of the shadows for a congressional interrogati...

The US has a high drug prices problem. These obscure but powerful companies will now face some tough questions on Capitol Hill.

The top scientist at AveXis told us the ‘unique’ strength that powered its $9 billion sale to Novartis, and it could shape the future of g...

Manufacturing has emerged as a huge challenge for the booming gene therapy industry because these products are so new and complex.
A trader passes by a screen displaying the tickers symbols for Bristol-Myers Squibb and Intelsat, Ltd. on the floor at the New York Stock Exchange, April 25, 2013. World equity markets advanced on Thursday as solid corporate earnings and data indicating the U.S. labor market remains resilient despite signs of slower growth buoyed optimism about the economy, an outlook that sent bond prices lower.

The record breaking $74 billion BMS-Celgene takeover just got the green light from 2 key players

The deal has faced growing unhappiness from shareholders, who had been hoping for a different type of acquisition.
A new class of innovative "gene therapies" make it possible to treat disease at the genetic level, and bring difficult ethical questions with them.

Bill Gates is worried about gene editing worsening inequality. Now a top ethicist is raising new red flags.

New technology has made it possible to tinker with the very DNA that makes us who we are, offering fresh hope of new cures for difficult diseases.
A sign marks a Biogen facility in Cambridge.

Biogen is crashing after scrapping its late-stage Alzheimer’s drug trials

Biogen shares crashed more than 25% in pre-market trading after discontinuing two late-stage Alzheimer's drug trials with Eisai.
A Memphis Meats chicken strip.

Silicon Valley startups backed by celebrities like Bill Gates are using gene-editing tool Crispr to make meat without farms — and to disrupt a $...

Startups backed by celebrities like Bill Gates and Richard Branson are experimenting with gene-editing to make lab-grown chicken, pork, and beef. It's the first known instance of Crispr being used in a new meat product.
Swedish pharma billionaire Frederik Paulsen made this year's Forbes list.

Meet the 10 richest billionaires in healthcare, whose ranks include a doctor and heirs to pharmaceutical empires

Forbes just released its ranking of the world's richest billionares. Here are the 10 richest billionaires in healthcare and biotech.